|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/29/20 Jrsis Health Care Corp 10-Q 3/31/20 78:3.6M Edgar Agents LLC/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 273K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 25K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 25K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 22K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 22K
12: R1 Document and Entity Information HTML 54K
13: R2 Consolidated Balance Sheets HTML 127K
14: R3 Consolidated Balance Sheets (Parenthetical) HTML 30K
15: R4 Consolidated Statements of Operations and HTML 125K
Comprehensive Income (Unaudited)
16: R5 Consolidated Statement of Sharesholders' Equity HTML 45K
(Unaudited)
17: R6 Consolidated Statements of Cash Flows (Unaudited) HTML 104K
18: R7 Description of Business and Organization HTML 28K
19: R8 Summaries of Significant Accounting Policies HTML 90K
20: R9 Accounts Receivable, Net HTML 27K
21: R10 Inventories HTML 27K
22: R11 Prepayment HTML 26K
23: R12 Property and Equipment HTML 31K
24: R13 Long Term Deferred Expenses HTML 25K
25: R14 Right-of-Use Assets and Lease Liabilities HTML 58K
26: R15 Derivative Financial Instruments HTML 29K
27: R16 Non-controlling Interests HTML 25K
28: R17 Revenue HTML 34K
29: R18 Income Tax Expense HTML 27K
30: R19 Related Party Transactions HTML 38K
31: R20 Basic and Diluted Earnings Per Share HTML 31K
32: R21 Contingencies and Commitment HTML 26K
33: R22 Common Stock HTML 23K
34: R23 Going Concern HTML 26K
35: R24 Subsequent Events HTML 24K
36: R25 Summaries of Significant Accounting Policies HTML 141K
(Policies)
37: R26 Summaries of Significant Accounting Policies HTML 53K
(Tables)
38: R27 Accounts Receivable, Net (Tables) HTML 26K
39: R28 Inventories (Tables) HTML 28K
40: R29 Prepayment (Tables) HTML 25K
41: R30 Property and Equipment (Tables) HTML 29K
42: R31 Right-of-Use Assets and Lease Liabilities (Tables) HTML 48K
43: R32 Revenue (Tables) HTML 33K
44: R33 Related Party Transactions (Tables) HTML 34K
45: R34 Basic and Diluted Earnings Per Share (Tables) HTML 31K
46: R35 Description of Business and Organization (Details) HTML 40K
47: R36 Summaries of Significant Accounting Policies HTML 31K
(Details)
48: R37 Summaries of Significant Accounting Policies HTML 43K
(Details 1)
49: R38 Summaries of Significant Accounting Policies HTML 32K
(Details 2)
50: R39 Summaries of Significant Accounting Policies HTML 28K
(Details 3)
51: R40 Summaries of Significant Accounting Policies HTML 41K
(Details 4)
52: R41 Summaries of Significant Accounting Policies HTML 27K
(Details 5)
53: R42 Summaries of Significant Accounting Policies HTML 38K
(Details Textual)
54: R43 Accounts Receivable, Net (Details) HTML 30K
55: R44 Accounts Receivable, Net (Details Textual) HTML 24K
56: R45 Inventories (Details) HTML 32K
57: R46 Prepayment (Details) HTML 30K
58: R47 Property and Equipment (Details) HTML 45K
59: R48 Property and Equipment (Details Textual) HTML 23K
60: R49 Long Term Deferred Expenses (Details) HTML 33K
61: R50 Right-of-Use Assets and Lease Liabilities HTML 41K
(Details)
62: R51 Right-of-Use Assets and Lease Liabilities (Details HTML 32K
1)
63: R52 Right-of-Use Assets and Lease Liabilities (Details HTML 32K
2)
64: R53 Right-of-Use Assets and Lease Liabilities (Details HTML 32K
3)
65: R54 Right-of-Use Assets and Lease Liabilities (Details HTML 68K
Textual)
66: R55 Derivative Financial Instruments (Details) HTML 40K
67: R56 Non-controlling Interests (Details) HTML 36K
68: R57 Revenue (Details) HTML 41K
69: R58 Income Tax Expense (Details) HTML 35K
70: R59 Related Party Transactions (Details) HTML 33K
71: R60 Related Party Transactions (Details 1) HTML 28K
72: R61 Related Party Transactions (Details Textual) HTML 31K
73: R62 Basic and Diluted Earnings Per Share (Details) HTML 43K
74: R63 Common Stock (Details) HTML 29K
75: R64 Going Concern (Details) HTML 25K
77: XML IDEA XML File -- Filing Summary XML 140K
76: EXCEL IDEA Workbook of Financial Reports XLSX 87K
6: EX-101.INS XBRL Instance -- jrss-20200331 XML 972K
8: EX-101.CAL XBRL Calculations -- jrss-20200331_cal XML 182K
9: EX-101.DEF XBRL Definitions -- jrss-20200331_def XML 475K
10: EX-101.LAB XBRL Labels -- jrss-20200331_lab XML 927K
11: EX-101.PRE XBRL Presentations -- jrss-20200331_pre XML 680K
7: EX-101.SCH XBRL Schema -- jrss-20200331 XSD 181K
78: ZIP XBRL Zipped Folder -- 0001213900-20-016048-xbrl Zip 117K
EXHIBIT 31.2
Certification of Principal Financial Officer
Section 302 Certification
I, Xuewei Zhang, certify that:
1. I have reviewed this quarterly report on Form 10-Q of JRSIS HEALTH CARE CORPORATION;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and the internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
| Date: | June 29, 2020 | /s/ Xuewei Zhang |
|
Xuewei Zhang, Chief Financial Officer | ||
| (Principal Financial Officer) |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 6/29/20 | None on these Dates | ||
| For Period end: | 3/31/20 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/21/20 Jrsis Health Care Corp. POS AM 2:324K EdgarAgents LLC/FA |